The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
841
April 5, 1991
View Complete Issue         Table of Contents 2019 
Alprazolam For Panic Disorder
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Alprazolam For Panic Disorder
April 5, 1991 (Issue: 841)
Alprazolam (Xanax - Upjohn), a triazolobenzodiazepine previously available in the USA for treatment of anxiety (Medical Letter 24:41, 1982), was recently approved by the US Food and Drug Administration (FDA) for treatment of panic disorder, with or...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Alprazolam For Panic Disorder
Article code: 841b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.